Protein-bound paclitaxel
It is manufactured and sold in the United States by Celgene under the trade name Abraxane where it is designated as an orphan drug as first-line treatment , in combination with gemcitabine , for the orphan disease "metastatic adenocarcinoma of the pancreas" . 
<triplet> Celgene <subj> United States <obj> country